[Therapy of hypertensive heart disease: vasodilator agents in the forefront].
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications*; D009842:Oligopeptides / Q000627:therapeutic use; D013722:Teprotide; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D009842:Oligopeptides; D014665:Vasodilator Agents; D013722:Teprotide
Therapie der hypertensiven Herzkrankheit: Vasodilatatoren im Vordergrund.